Blood pressure as a cardiovascular risk factor: Prevention and treatment

JAMA

Volumn 275, Issue 20, 1996, Pages 1571-1576

  Kannel, William B ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CORONARY RISK; DYSLIPIDEMIA; FEMALE; GLUCOSE INTOLERANCE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT PLANNING; UNITED STATES;

EID: 0029886630     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.20.1571     Document Type: Article

References (29)

1. Wilson PWF, Kannel WB. Hypertension, other risk factors and the risk of cardiovascular disease. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management, I. 2nd ed.New York, NY: Raven Press; 1995:99-114.
2. Cupples LA, D'Agostino RB. Some Risk Factors Related to the Annual Incidence of Cardiovascular Disease and Death Using Pooled Repeated Biennial Measurements: Framingham Heart Study: 30-Year Follow-up. Washington, DC: US Dept of Health and Human Services, Public Health Service, National Heart, Lung, and Blood Institute; 1987. National Institutes of Health document 87-2703.
3. Working Group Report on Primary Prevention of Hypertension: National High Blood Pressure Education Program. Bethesda, Md: National Institutes of Health; 1993. National Institutes of Health, National Heart, Lung, and Blood Institute document 93-2669.
4. 1988 Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The 1988 report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med. 1988;148:1023-1038.
5. Belanger A, Cupples LA, D'Agostino RB. Means at Each Examination and Inter-examination Consistency of Specified Characteristics: Framingham Heart Study: 30- Year Follow-up. Washington, DC: US Dept of Health and Human Services; 1988. Public Health Service, National Institutes of Health document 80-2970.
6. Kannel WB, Garrison RJ, DannenbergAL. Secular trends in blood pressure in normotensive persons: the Framingham Study. Am Heart J. 1993; 125:1154-1158.
7. Kannel WB. Rationale for treatment of hypertension in the elderly. Am J Geriatr Cardiol. May/ June 1994;3:33-45.
8. Kannel WB, Dannenberg AL, Abbott RD. Unrecognized myocardial infarction and hypertension: the Framingham Study. Am Heart J. 1985;109:581-585.
9. Kannel WB. Epidemiology of essential hypertension: the Framingham experience. Proc R Coll Phys Edinb. 1991;21:273-287.
10. Cruickshank JM. Coronary flow reserve and the J-curve relation between diastolic blood pressure and myocardial infarction. BMJ. 1988;297:1227-1230.
11. Alderman MH, Ooi WL, Modhaven S, Cohen H. Treatment-induced blood pressure reduction and the risk of myocardial infarction. JAMA 1989;262: 920-924.
12. D'Agostino RB, Belanger AJ, Kannel WB. Relation of low blood pressure to coronary heart disease in the presence of myocardial infarction. BMJ. 1991;303:385-389.
13. Kannel WB, Dannenberg AL, Levy D. Population implications of electrocardiographic left ventricular hypertrophy. Am J Cardiol. 1987;60:851-931.
14. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Study. N Engl J Med. 1990;322: 1561-1566.
15. Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation. 1994;90:1786-1793.
16. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Study. J Am Coll Cardiol. 1995;25:879-884.
17. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a meta-analysis of 109 treatment studies. Am J Hypertens. 1992;5:95-110.
18. Reaven GM. Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia and coronary heart disease. Am Heart J. 1991;121:1283-1288.
19. Anderson KM, Wilson PWF, Odell PM, Kannel WB. Updated coronary risk profile. Circulation. 1991;83:357-363.
20. Leaverton PE, Sorlie PD, Kleinman JC, et al. Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study. J Chronic Dis. 1987; 40:775-784.
21. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22:312-318.
22. Dannenberg AL, Garrison RJ, Kannel WB. Incidence of hypertension in the Framingham Study. Am J Public Health. 1988;7:676-679.
23. Cornoni-Huntley J, LaCroix A, Havlik RJ. Race and sex differentials in the impact of hypertension in the United States: the NHANESI epidemiologic follow-up study. Arch Intern Med. 1989;149:780-788.
24. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183.
25. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265: 3255-3264.
26. Garrison RJ, Kannel WB, Stokes J III, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med. 1987;16:234-251.
27. Stamler R, Stamler J, Bosch FC, et al. Primary prevention of hypertension by nutritional hygienic means: final report of a randomized controlled trial. JAMA. 1989;262:1801-1807.
28. Hypertension Prevention Trial Group. The hypertension prevention trial: three-year effects of dietary changes on blood pressure. Arch Intern Med. 1990;150:153-162.
29. The Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high-normal levels: results of trials of hypertension prevention, phase I. JAMA 1992;267:1213-1220.